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Summary. The response of EMT6 mouse tumour cells to ICRF 159, both with
and without X-radiation, has been measured during the life of monolayer cultures.
The cytotoxic effect of ICRF 159 was found to be proliferation-dependent. Flow
cytofluorimetry studies of cell cycle distribution showed that ICRF 159 prevented
cell division while allowing DNA synthesis to continue. This anti-mitotic action
and the cytotoxic effect of the drug were found to be closely related. Increased
sensitivity to X-radiation was observed in cultures pretreated for24 h with200 ,ug/ml
ICRF 159. In exponential and early plateau cultures this was seen as a reduced
shoulder of the survival curve. In late plateau cultures there was no apparent
reduction of the shoulder, but an increase in slope.
ICRF 159, ((jA)-1,2,-bis(3,5-dioxopi-
perazin-1-yl) propane), is a cytotoxic
agent which has been shown to kill
cells during a brief period of the cell
cycle (Hellmann and Field, 1970). Using
synchronized cultures of human lympho-
cytes stimulated into division by phyto-
haemagglutinin, Sharpe, Field and Hell-
mann (1970) showed that ICRF 159
prevented these cells from entering mitosis.
This effect was only found when the
cells were exposed to the drug during the
premitotic (G2) phase, with little or no
effect from exposures to the drug at other
phases ofthe cell cyckb. Similarly, studies
on erythroid maturation in C57BL mice
indicate that the drug has a similar
action in vivo (Blackett and Adams,
1972). In studies using the spontaneously
metastasizing Lewis lung tumour, ICRF
159 has been shown to function as an
antimetastatic agent at doses which have
little effect on the primary growth (Bur-
rage, Hellmann and Salsbury, 1970;
Salsbury, Burrage and Hellmann, 1970).
This action has been attributed to a
normalization of tumour vasculature in
ICRF 159-treated tumours. This angio-
metamorphic effect may then prevent
dissemination of cells from the primary
growth (LeServe and Hellmann 1972;
James and Salsbury, 1974; Salsbury,
Burrage and Hellmann, 1974). The anti-
metastatic effecthasnot,however, beende-
monstratedinotherspontaneouslymetasta-
sizing systems (Pimm and Baldwin, 1975).
Potentiation of X-ray lethality by
ICRF 159 has also been observed in
experimental tumours (Hellmann and
Murkin, 1974; Norpoth et.al., 1974) and
also reported in the clinical situation
(Ryall et al., 1974). It has been suggested
that this might be due to the improved
blood supply resulting from the angio-
metamorphic effect, with a consequent
rise in oxygen tension in the tumour
tissue and increased radiosensitivity (Nor-
poth et al., 1974).
Should X-ray potentiation by ICRF
159 be due solely to the improved tumour
vasculature, rather than a direct effect
on the tumour cells, then no such poten-
tiation should occur in monolayer cell
cultures growing in vitro. It was to
clarify this point that the following work
was undertaken.I. W. TAYLOR AND N. M. BLEEHEN
METHODS
Cell line
The cells used in this study were EMT6/
M/CC. Cells were cultured in 30-ml plastic
flasks (NUNC (UK) Ltd) containing 5 ml
of Eagle's MEM supplemented with 20%
calf serum and gassed with a mixture of
95% air and 5% CO2. Full culture details
have been reported previously from our
laboratory (Twentyman et al., 1975).
Cell kinetics
The proliferation kinetics of this cell
line have been described fully (Twentyman
et al., 1975).
Three distinct growth phases can be
identified during the life of monolayer
cultures of EMT6 cells.
1. Exponentialphase.-This occurs during
the first 3 days after inoculation of 105
cells into a flask. During this time, after
an initial lag, the cells increase in number
exponentially and have a labelling index
(LI) of 55-60%. All the cells are in the
division cycle, with a mean cell cycle time
of 12-14 h.
2. Early plateau phase.-When the cul-
ture medium in the flasks is changed daily
from Day 2 after inoculation of the cells,
there is no further increase in cell numbers
from Day 4 onwards. Between Day 4
and Day 8 the LI falls to about 25%. The
mean cycle time is 32-40 h and 50% of the
cells are either out of the division cycle or
have an extremely long cycle time.
3. Late plateau phase.-Cells show a
further change in kinetic characteristics
from Day 8, wlhen LI approaches zero.
The cells may now be regarded as essentially
non-proliferating.
In the present series of experiments,
flasks for early and late plateau-phase
cultures were inoculated with 105 cells from
early plateau-phase stock cultures and the
medium changed from Day 2. Flasks for
exponential-phase cultures were inoculated
with similar cells, but at a reduced number
of 3-5 x 104. This was to ensure expo-
nential growth over the period examined.
The medium was not changed during
this time. In all the experiments to be
described, cells were allowed to grow un-
disturbed in the flasks for 48 h before treat-
ment.
Radiation treatment
Irradiations were carried out using 250 kV
X-rays from a Pantak machine, with a
dose rate of about 63 rad/min. The cells
were irradiated at room temperature, whilst
covered with medium and attached to the
surface of the plastic flasks.
ICRF 159 treatment
A quantity of ICRF 159 was dissolved
in 04M HCI to produce a solution which
was at 50 x the final concentration required
in the culture flasks. This stock solution was
sterilized by millipore filtration, and 01 ml
was then added to each experimental flask.
0 1 ml of 04M HCI was added to control
flasks.
Survival assay
Immediately after irradiation or ICRF
159 treatment, the cells were removed from
the surface of the flask by 15 min incubation
with 0.075% trypsin solution. Two washes
were used to ensure adequate removal of
the drug. Following resuspension in medium,
the cells were counted in a haemocytometer.
After the appropriate dilutions, the cells
were plated into 50-mm plastic culture
dishes (Sterilin). These were incubated at
37°C for 10 days in plastic boxes gassed
with 95% air and 5% C02 and at high humi-
dity. Survival was determined at the end
of this time by fixing and staining, and
counting colonies containing 50 or more
cells.
Flow cytofluorimetry (FCF)
The method of staining cell nuclei for
this technique has been fully described by
Krishan (1975).
Briefly, the cells to be analysed were
removed from the flasks by trypsinization,
resuspended in medium and then spun
down at 200 g for 5 min. The resulting cell
pellet was resuspended in an ice-cold hypo-
tonic Na citrate solution (1 g/l) containing
0-005% propidium iodide, a fluorescent
DNA-coupling agent. Lysis of the cells
occurs, and 10-15 min was allowed for
complete staining of the intact nuclei.
Histograms of the nuclear DNA content
were then obtained using a Biophysics
Model 4800A Cytofluorograf (Shandon Instru-
ments Ltd).
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TABLE. -Computed Parameters ofRadiation Response Data Treated in 3 Growth Phases
Do Dq
Growth phase ICRF 159 (rad) n (rad)
Exponential 129 (114-148) 51 (18-147) 509
(LI = 60%)* + 114 (94-145) 3 (1-10) 129
Early Plateau 137 (125-152) 44 (20-97) 517
(LI = 25%)* + 116 (102-135) 9 (3-24) 254
Late Plateau 127 (114-144) 13 (6-28) 322
(LI = 1<%)* + 100 (89-114) 29 (9-94) 337
95% confidence limits in parentheses.
+ ICRF 159 (200 ,ig/ml) for 24 h before X-rays.
* Labelling index (LI) from previous laboratory data.
RESULTS
All points shown in the figures repre-
sent a surviving fraction estimated from
the mean colony count on 4 replicate
dishes. The errors associated with indi-
vidual determinations were small com-
pared with the spread of results between
separate determinations. Where sample
errors have been shown, these have been
calculated from the Poisson variance as
described by Boag (1975). The errors
shown in the Table are for the aggregated
results and are calculated from the
regression analysis.
(i) Dose response (Fig. 1)
The surviving fraction ofexponentially
growing cells falls rapidly as the con-
centration of ICRF 159 is increased to
a threshold level of about 1 ,ag/ml.
Thereafter a plateau is reached, with no
further change in surviving fraction at
concentrations up to 10 ,ug/ml. At higher
concentrations a significant increase
(P < 0-01) in surviving fraction is ob-
served, from 0-08 at 10 ,ug/ml to 0*20
at 200 ,tg/ml, where once again a plateau
is reached. Early and late plateau cul-
tures show a progressively decreasing
response to the drug, with surviving
fractions of 0-60 and 0'80 respectively
after 24 h exposure to 200 ,ug/ml of
ICRF 159.
(ii) Time response (Fig. 2)
The response to 200 ,ug/ml ICRF 159
for various continuous exposure times
is also seen to decrease as the size of the
proliferative component of the cell cul-
tures decreases as the cells progress
from exponential phase to late plateau
phase.
The curve for exponentially growing
cells is biphasic. A linear response with
time is observed for the first 12 h of
exposure to the drug, reducing the sur-
viving fraction to about 0 35. (The mean
cell-cycle time for untreated cells is
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FIG. 1.-Change insurviving fraction ofEMT6
cells, at 3 phases of growth, with dose of
ICRF 159 administered 24 h previously.
Lines drawn by eye. Error bars show
± 2 x s.e. calculated from the Poisson
variance.
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FIG. 2.-Change in surviving fraction of
EMT6 cells, at 3 phases of growth, with
time after administration of ICRF 159
(200yg/ml). Lines drawrn by eye.
12-14 h.) Exposures to ICRF 159 for
times greater than 12 h result in a reduced
rate of cell killing, resulting in a deviation
from the initial linear response. The
biphasic nature of the curve becomes
more apparent when exposure times
>24 h are examined (Fig. 7).
(iii) Radiation response (Figs. 3, 4)
We found little difference between
the radiation response of untreated ex-
ponential and early plateau phase cul-
tures. Both curves have a wide shoulder
region, as signified by the relatively high
extrapolation numbers (n 51 and 44
respectively) with values of Dq around
500 rad (Table). By comparison, late
0\0
0\
RADIATION DOSE (rad)
FIG. 3. Change in surviving fraction of ex-
ponential-phase cultures of EMT6cells with
dose of X-radiation. Open symbols-X-
radiation alone. Closed symbols-cells
exposed to ICRF 159 (200 pg/ml) 24 h
before X-radiation. Interrupted line-
ICRF 159 + X-radiation results normal-
ized to unity. Exponential portion of
curves fitted by regression analysis, shoul-
der portion drawn by eye.
plateau-phase cultures have a lower
extrapolation number (13) and a reduced
Dq (322 rad). All 3 curves have similar
slopes (Do). Figs. 3 and 4 show the
radiation survival curves of exponential
phase and late plateau-phase cultures
after a 24-h exposure to 200 ,tg/ml of
ICRF 159, compared with those of cells
irradiated in the absence of drug. Again
the responses of exponential and early
plateau phase cultures were found to be
similar. The observed changes in the
values of n and Dq, however, were smaller
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FIG. 4. Change in surviving fraction of late
plateau-phase cultures of EMT6 cells with
dose of X-radiation. Open symbols
X-radiation alone. Closed symbols-cells
exposed to ICRF 159 (200 pg/ml) 24 h be-
fore X-radiation. Interrupted line-ICRF
159 + X-radiation results normalized to
unity. Exponentialportion ofcurvesfitted
by regression analysis, shoulder portion
drawn by eye.
for early plateau than for exponential
cultures (Table). To demonstrate whe-
ther pretreatment with ICRF 159 had
an additive or a potentiating effect on
the radiation response of the cultures,
the curves showing the combined treat-
ment were normalized to unity (inter-
rupted line) to account for the drug's
cytotoxic effect. Values -of n, Do and
Dq for the combined treatment, shown
in the Table, were calculated from the
normalized curves.
In exponential and early plateau
cultures the effect of the combined treat-
ment can be seen to be more than additive.
This potentiating effect is greater in
exponential cultures, with decreases in
values of n, from 51 to 3, and Dq, from
509 to 129 rad, than in early plateau
cultures (n - 9 and Dq 254 rad). The
drug treatment appears to have no effect
on the Do slope of either of these curves.
In late plateau-phase cultures, how-
ever, the reverse situation occurs. The
combined treatment has no significant
effect on the values of n and Dq when
compared with the radiation-alone curves,
but causes a significant increase in the
slope, with a corresponding decrease in
Do from 127 to 100 rad.
(iv) Nuclear DNA analysis (Fig. 5)
We have used the FCF technique to
determine the relative nuclear DNA
content of EMT6 cell populations, and
thus show the proportion of cells occupy-
ing each phase of the cell cycle. The
y axis of the histograms represents the
number of cells, and the relative DNA
content is on the x axis. Each histogram
represents 10,000 cells.
The histogram for a control population
of exponentially growing asynchronous
cells shows that most of the cells have
a nuclear DNA content corresponding
to G1 or S, with a relatively small number
in G2. However, after a 24-h exposure
to 200 ,ug/ml of ICRF 159, the distribu-
tion of nuclear DNA content has altered
significantly. Although permitting cell
cycle progression, ICRF 159 appears to
prevent cells from passing through mitosis.
Cells therefore accumulate at a point
in the cycle corresponding to the DNA
content of G2 cells.
The drug-induced accumulation of
cells is consistent with the known pro-
portion of dividing cells present in ex-
ponential cultures (100%), early plateau
cultures (50%) and later plateau cultures
(<1%). ICRF 159 appears to have no
effect on the non-proliferating cells of
these cultures.
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Fic.. 5.-FCF analysis of cell-cycle distri-
bution of EMT6 cells, at 3 phases of
growth, before and after 24 h exposure to
ICRF 159 (200 ,tg/ml). Ordinate repre-
sents frequency of cells containing a con-
centration of nuclear DNA shown on the
abscissa. N represents cell ploidy, 2N and
4N being the normal pre- and post-S DNA
content.
DISCUSSION
The cytotoxicity of ICRF 159 on
EMT6 tumour cells grown in vitro ap-
pears to be highly dependent on the
proliferating ability ofthe cultures. Thus,
cytotoxicity decreases as the non-pro-
liferating component of the cell culture
increases. This cycle specificity has been
reported by other workers, both in vivo
(Blackett and Adams 1972) and in vitro
(Hallowes, West and Hellmann, 1974)
using other cell systems.
The manifestations of the cytotoxicity
of ICRF 159 on exponentially growing
cultures of EMT6 cells would, however,
appear to be rather more complex than
those observed by other workers using
other cell lines. Hellmann and Field
(1970) found that exposure of Hep/2
cells to various concentrations of ICRF
159 caused a nearly linear fall in cell
survival, approaching zero at drug-ex-
posure times equivalent to one cell cycle.
It was concluded that cells were, there-
fore, being killed as they passed through
that part of the cycle sensitive to ICRF
159. The small deviation from linearity
of the curve was accounted for by the
presence of a small number of more slowly
dividing cells. Using EMT6 cells, an
exponential decrease in survival is also
observed for drug exposures up to 12-14 h
(about 1 cell cycle time). However, at
this time the surviving fraction is still
relatively large (,0.30). Even after drug
exposure times of 24 h the surviving
fraction is 0-20. There is also a con-
siderable deviation from the initial ex-
ponential decline at drug-exposure times
greater than 12 h. Previous studies on
exponential cultures of EMT6 cells (Twen-
tyman et al., 1975) have indicated that
all cells are in cycle, with very few cells
with cycle times in excess of 12-14 h.
There are two probable explanations
for this deviation of the curve. Firstly,
we could be dealing with a heterogenous
cell population, with respect to ICRF 159
sensitivity. More sensitive cells would
be killed rapidly with early exposure to
the drug, thus leaving a more resistant
population. Alternatively, the concen-
tration of ICRF 159 used could increase
the time taken for cells to reach a sensitive
phase of the cell cycle. The latter
proposal seems more likely, in view of
the response of exponential cultures to
various ICRF 159 concentrations for
24 h (Fig. 1). Relatively low concen-
trations of ICRF 159 (5-10 ,ug/ml) have
a more lethal effect than much higher
concentrations (200,ug/ml). This effect
has also been reported for BHK-21S
cells grown in culture (Stephens, 1974).
FCF analysis of cultures exposed to
10 jtg/ml (Fig. 6 a) show that although
the drug prevents cell division, as seen
by the absence of cells returning to a
G1 complement of DNA, this drug con-
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FIG. 6. FCF analysis of cell-cycle distri-
bution of exponential cultures of EMT6
cells 12 h and 24 h after exposure to ICRF
159: (a) 10 ,ug/ml and (b)-200 ,cg/ml.
Ordinate represents frequency of cells con-
taining a concentration of nuclear DNA
shown on the abscissa. N represents cell
ploidy, 2N and 4N being the normal pre-
and post-S DNA content.
centration allows the cells to continue
DNA synthesis at an almost normal
rate. Thus the cells double their DNA
content twice in 24 h (2 cell-cvcle times).
However, a drug concentration of 200
,tg/ml appears to exert a cytostatic
effect once the cells have completed the
first cell cycle, thus significantly reducing
the rate of DNA synthesis thereafter
(Fig. 6b). Comparison of cell-survival
data for the time response to drug con-
centrations of 10 ,ug/ml and 200 ,ug/ml
(Fig. 7) adds further credence to this
explanation. Both concentrations have
similar cytotoxicities for the first 12 h of
exposure, which increase linearly with
time. Thereafter, the rate of cell killing
continues linearly with a drug concen-
tration which has little or no cytostatic
effect (10 jug/ml) but falls off rapidly
with the onset of the proliferation block
caused by 200 ,ug/ml.
These results show that cells are
not only susceptible to the cytotoxicity
of ICFR 159 at the boundary of G2
and mitosis, but are equally sensitive
afterwards, provided the drug concentra-
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FiG. 7.- Change in surviving fraction of
exponential cultures of EMT6 cells with
time after administration of ICRF 159.
O 200,cg/ml; A 10 ,ug/ml. Lines drawn
by eye. Symbols indicate the mean values
of 4 experiments, except for the 24-h and
36-h points, where the numbers of experi-
ments are shown in parentheses. For
clarity, error bars (+ 2 x s.e.) are shown
only where a significant difference occurs.
tion allows continuation ofDNA synthesis.
We are undertaking further studies to
clarify this observation.
ICRF 159 has the ability to potentiate
radiation lethality in vivo (Hellmann and
Murkin, 1974; Norpoth et al., 1974).
This effect has not, to our knowledge,
been previously studied in vitro, apart
from one unpublished reported by Dawson
that no such potentiation was observed
in HeLa cells after a short exposure to
ICRF 159. The results in the Table
demonstrate that ICRF 159 is capable
of potentiating radiation in cultures of
EMT6 cells. As with the drug's cyto-
toxic action, this effect is largely de-
pendent on the proportion of proliferating
cells in the cell population.
The radiation-potentiation effect ap-
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ways. In exponential and early plateau
cultures the increase in radiation sensi-
tivity appears to be entirely due to a
decrease in the width of the shoulder,
as shown by decreases in the values
of n and Dq. The width of the shoulder
of the radiation-response curve is thought
to be associated with the cell's ability
to accumulate and repair sublethal radia-
tion damage (Elkind and Sutton, 1959).
Preliminary experiments with split doses
of radiation appear to confirm that
ICRF 159 is substantially reducing this
capability. We will be reporting the
split-dose radiation results fully in a
later communication. With late plateau
cells, however, ICRF 159 has little, if
any, effect on the shoulder. Instead it
causes a small but significant increase
in the slope of the curve. It is possible
that both effects occur in the exponential
and early plateau cultures, but that the
large shoulder component of these cul-
tures, much reduced in late plateau
cultures, is masking the small changes in
the slope.
These results show that ICRF 159
has the ability to potentiate radiation
lethality in a system in which the drug's
ability to alter tumour vasculature can
play no part. The presence of more
than one mechanism of potentiation in
vitro is possible, as seen from the dif-
ferences between the exponential and late
plateau cultures. This does not exclude
the possibility that there may be further
mechanisms operating in vivo, such as
the angiometamorphic effect.
We are currently investigating the
mechanism ofICRF 159 radiopotentiation
and the relationships between cell cycle
and drug sensitivity, using the EMT6
cell line grown both in vitro and in vivo.
We would like to thank Dr J. V.
Watson for his help with the FCF analysis.
ICRF 159 was kindly supplied to us
by Dr A. Creighton and Professor K.
Hellmann ofthe Imperial Cancer Research
Fund Laboratories, London.
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